Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study

Purpose The ORIENT-12 study demonstrated the promising results of sintilimab combined with gemcitabine and platinum (GP) therapy in squamous non-small-cell lung cancer (sqNSCLC) patients. However, the efficacy of sintilimab plus paclitaxel/nab-paclitaxel and platinum (TP) in sqNSCLC is not yet known...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2023-02, Vol.149 (2), p.757-764
Hauptverfasser:	Lin, Xinqing, Deng, Haiyi, Li, Suyang, Xie, Xiaohong, Chen, Chao, Cai, Longqiu, Yang, Yilin, Qiu, Guihuan, Xie, Zhanhong, Qin, Yinyin, Liu, Ming, Zhou, Chengzhi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Antineoplastic Combined Chemotherapy Protocols - adverse effects Cancer Research Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - etiology Chemotherapy Gemcitabine Hematology Humans Internal Medicine Lung cancer Lung Neoplasms - pathology Medicine Medicine & Public Health Metastases Metastasis Non-small cell lung carcinoma Oncology Original Article – Clinical Oncology Paclitaxel Patients Platinum Prospective Studies Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!